The real-world burden and cost of diabetes: Results from the iNPHORM study
Speaker: Stewart Harris 30.09.2021 18:15-18:45 Berlin Hall
Speaker: Stewart Harris 30.09.2021 18:15-18:45 Berlin Hall
09:15 – 09:35 How and why to identify high-risk patients: lessons from the clinic Elmar Jaeckel (GER)Lise Lotte Gluud (DNK) 09:35 – 09:45 The future
Outcomes of an EU Advisory Board on digital therapeutics and a look at OneTouch Reveal remote monitoring usage in real life 18:15 – 18:20 Introductions
Presenter: Juan Pablo Frias (USA) Glucose monitoring interferences when using BGM/CGM. 30.09.2021 09:15 – 09:45 Meet the Expert
Speaker: Michael Nauck (GER) 09:35 – 09:36 Introduction 09:36 – 09:44 The incretin journey: Past, present and future 09:44 – 09:45 Summary 30.09.2021 09:35 –
20:00 – 20:05 Welcome and Introductions Bo Ahrén (SWE) 20:05 – 20:40 Health risks associated with elevated postprandial glucose or increased glycaemic variability Louis Monnier
Faculty: David Cherney (CAN), Kim Connelly (CAN), Sam Dagogo-Jack (USA) 18:15 – 18:20 Opening Remarks Sam Dagogo-Jack (USA) 18:20 – 18:43 Cross-talk between the Heart,
18:15 – 18:20 Introduction to faculty and program Cecilia Low Wang (USA) 18:20 – 18:22 Introduction to the Case Justin Morrison (USA) 18:22 – 18:25
Speaker: Javed Butler (USA) 30.09.2021 18:05 – 18:15 Paris Hall
